Aditxt (ADTX) Common Equity (2019 - 2026)
Aditxt (ADTX) recorded quarterly Common Equity of -$33.3 million in Q1 2026, down 693.2% quarter-over-quarter from $5.6 million in Q4 2025, and down 294.4% on a YoY basis from $17.1 million in Q1 2025.
Aditxt (ADTX) Common Equity (2019 - 2026) Analysis & Trends
Aditxt's Common Equity history runs 8 years deep, the most recent figure standing at -$33.3 million for Q1 2026.
- In Q1 2026, Common Equity fell 294.4% year-over-year to -$33.3 million; the TTM figure through Mar 2026 stood at -$33.3 million (down 294.4% YoY), while the FY2025 annual figure was $5.6 million, up 413.99% from the prior year.
- Common Equity was -$33.3 million for Q1 2026 at Aditxt, down from $5.6 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $17.1 million in Q1 2025 to a low of -$33.3 million in Q1 2026.
- Historically, Common Equity has averaged $2.8 million across 5 years, with a median of $4.7 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Common Equity tumbled 384.3% in 2023, then surged 14270.57% in 2024.
- A 5-year view of Common Equity shows it stood at $5.2 million in 2022, then jumped by 208.22% to $16.0 million in 2023, then sank by 93.2% to $1.1 million in 2024, then soared by 413.99% to $5.6 million in 2025, then sank by 693.2% to -$33.3 million in 2026.
- The last three Common Equity figures came in at -$33.3 million (Q1 2026), $5.6 million (Q4 2025), and -$8.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 35.63 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.42 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 13.21 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 11.87 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Aditxt | 2,485.68 | -2.16 Mn | 2,868.00 | -33.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.28 Mn |
| Dec 31, 2025 | 5.61 Mn |
| Sep 30, 2025 | -8.86 Mn |
| Jun 30, 2025 | 13.35 Mn |
| Mar 31, 2025 | 17.12 Mn |
| Dec 31, 2024 | 1.09 Mn |
| Sep 30, 2024 | 4.45 Mn |
| Jun 30, 2024 | 6.34 Mn |
| Mar 31, 2024 | 9.78 Mn |
| Dec 31, 2023 | 16.05 Mn |
| Sep 30, 2023 | -4.22 Mn |
| Jun 30, 2023 | -3.87 Mn |
| Mar 31, 2023 | 68,068.00 |
| Dec 31, 2022 | 5.21 Mn |
| Sep 30, 2022 | 12.69 Mn |
| Jun 30, 2022 | 1.36 Mn |
| Mar 31, 2022 | 4.72 Mn |
| Dec 31, 2021 | 10.18 Mn |
| Sep 30, 2021 | 12.97 Mn |
| Jun 30, 2021 | 5.96 Mn |